Article
Severe consequences of carbamazepine exposure in utero.
BMJ case reports - 4 Aug 2011
Bravo Antonio, Hernandez Dolores, Martinez-Villarreal Laura, Elizondo Gabriela, Esmer Carmen
Abstract excerpt
The 'foetal carbamazepine syndrome' is characterised by facial dysmorphism associated to cardiovascular, nervous system, urinary tract and skeletal anomalies. The authors present the case of a neonate born to a 33-year-old epileptic woman treated with long term carbamazepine (CMZ) therapy. Four of her pregnancies exposed to the drug showed bad outcomes. The actual pregnancy ended by caesarean section, a female...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
